Reckitt Benckiser Group plc (OTCMKTS:RBGLY) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Reckitt Benckiser Group plc (OTCMKTS:RBGLY) has been given an average rating of “Moderate Buy” by the seven ratings firms that are covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, three have given a hold rating and three have assigned a strong buy rating to the company.

RBGLY has been the topic of several research reports. JPMorgan Chase & Co. cut shares of Reckitt Benckiser Group from an “overweight” rating to a “neutral” rating in a research report on Thursday, August 29th. UBS Group raised shares of Reckitt Benckiser Group to a “strong-buy” rating in a research report on Wednesday, September 18th. Citigroup raised Reckitt Benckiser Group to a “strong-buy” rating in a research report on Tuesday, October 1st. Barclays upgraded Reckitt Benckiser Group to a “strong-buy” rating in a report on Friday, October 4th. Finally, Sanford C. Bernstein downgraded Reckitt Benckiser Group from a “strong-buy” rating to a “hold” rating in a report on Monday, November 4th.

Reckitt Benckiser Group Stock Performance

RBGLY opened at $12.04 on Tuesday. The company has a debt-to-equity ratio of 0.97, a current ratio of 0.69 and a quick ratio of 0.47. The stock’s 50-day moving average price is $12.31 and its 200 day moving average price is $11.63. Reckitt Benckiser Group has a 12-month low of $10.24 and a 12-month high of $15.03.

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.